These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38450584)

  • 1. Particulate matters 2.5 induce tumor progression in lung cancer by increasing the activity of hnRNPA2B1 resulting in retarding mRNA decay of oxidative phosphorylation.
    Bian W; Yu H; Zhang X; Wang Y; Ni B
    IUBMB Life; 2024 Aug; 76(8):563-576. PubMed ID: 38450584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
    Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
    J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HNRNPA2B1 promotes oral squamous cell carcinogenesis via m
    Wang X; Zhi M; Zhao W; Deng J
    IUBMB Life; 2024 Jul; 76(7):437-450. PubMed ID: 38265150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.
    Wu Z; Jiao M; Shu C; Zhang S; Wang J; Pu J; Zhu J; Zeng Y; Zhu Y; Liu Z
    Cell Commun Signal; 2024 Jun; 22(1):313. PubMed ID: 38844957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer.
    Chen ZY; Cai L; Zhu J; Chen M; Chen J; Li ZH; Liu XD; Wang SG; Bie P; Jiang P; Dong JH; Li XW
    Carcinogenesis; 2011 Oct; 32(10):1419-26. PubMed ID: 21642356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambient fine particulate matter inhibits 15-lipoxygenases to promote lung carcinogenesis.
    Li MY; Liu LZ; Li W; Ng CSH; Liu Y; Kong AWY; Zhao Z; Wang S; Qi H; Jia H; Yang S; Du J; Long X; Ho RLK; Chak ECW; Wan IYP; Mok TSK; Underwood MJ; Gali NK; Ning Z; Chen GG
    J Exp Clin Cancer Res; 2019 Aug; 38(1):359. PubMed ID: 31420013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway.
    Hu Y; Sun Z; Deng J; Hu B; Yan W; Wei H; Jiang J
    Tumour Biol; 2017 Mar; 39(3):1010428317694318. PubMed ID: 28351333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOP2 facilitates EZH2-mediated epithelial-mesenchymal transition by enhancing EZH2 mRNA stability via m5C methylation in lung cancer progression.
    Yang Y; Fan H; Liu H; Lou X; Xiao N; Zhang C; Chen H; Chen S; Gu H; Liu H; Wan J
    Cell Death Dis; 2024 Jul; 15(7):506. PubMed ID: 39013911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of hnRNPA2B1 inhibits malignant capability and promotes apoptosis via down-regulating Lin28B expression in ovarian cancer.
    Yang Y; Wei Q; Tang Y; Yuanyuan Wang ; Luo Q; Zhao H; He M; Wang H; Zeng Q; Lu W; Xu J; Liu T; Yi P
    Cancer Lett; 2020 Apr; 475():43-52. PubMed ID: 32006618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HNRNPA2B1 stabilizes NFATC3 levels to potentiate its combined actions with FOSL1 to mediate vasculogenic mimicry in GBM cells.
    Wang H; Shi Y; Zhou X; Zhang L; Yang A; Zhou D; Ma T
    Cell Biol Toxicol; 2024 Jun; 40(1):44. PubMed ID: 38862832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
    Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
    Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of MALAT1 on proliferation and apo- ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy.
    Ma J; Wu K; Liu K; Miao R
    Cancer Biomark; 2018; 22(1):63-72. PubMed ID: 29439314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer.
    Zhu J; Cai T; Zhou J; Du W; Zeng Y; Liu T; Fu Y; Li Y; Qian Q; Yang XH; Li Q; Huang JA; Liu Z
    J Exp Clin Cancer Res; 2021 Jun; 40(1):192. PubMed ID: 34108040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARHGAP24 inhibits cell proliferation and cell cycle progression and induces apoptosis of lung cancer via a STAT6-WWP2-p27 axis.
    Wang L; Shen S; Xiao H; Ding F; Wang M; Li G; Hu F
    Carcinogenesis; 2020 Jul; 41(5):711-721. PubMed ID: 31430374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non‑coding RNA LINC01748 exerts carcinogenic effects in non‑small cell lung cancer cell lines by regulating the microRNA‑520a‑5p/HMGA1 axis.
    Tan Y; Xu F; Xu L; Cui J
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34970695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PM2.5 exposure induces alveolar epithelial cell apoptosis and causes emphysema through p53/Siva-1.
    Xu F; Xu A; Guo Y; Bai Q; Wu X; Ji SP; Xia RX
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3943-3950. PubMed ID: 32329870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
    Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
    Ma S; Wang X; Zhang Z; Liu D
    Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer.
    Liu X; Li J; Huang Q; Jin M; Huang G
    Mol Med; 2024 Apr; 30(1):56. PubMed ID: 38671369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Se-methylselenocysteine inhibits the progression of non-small cell lung cancer via ROS-mediated NF-κB signaling pathway.
    Ge L; Liu P; Tian L; Li Y; Chen L
    Exp Cell Res; 2024 Jul; 440(1):114101. PubMed ID: 38815788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.